Drugs for Treating Mental Disorders: Technologies and Global Markets

Published - Jan 2011| Analyst - Marianna Tcherpakov| Code - PHM074A
Market Research Report Single User License: $2,750 Member Price: FREE

Report Highlights

The global mental health pharmaceutical market can be estimated at $80 billion in 2010. This market is expected to increase at a 1.9% compound annual growth rate (CAGR) over the forecast period to reach a value of $88 billion in 2015.

SCOPE OF REPORT

The subject of the mental health pharmaceutical industry is complex and requires a proper and timely evaluation of current products and most importantly new drug development trends. The geographic scope of this study covers U.S. and global companies. The report identifies the major drug categories in the mental health pharmaceutical industry such as antidepressants, anxiolytics, and other psychiatric drug categories. This study describes current products in each category, identifies current market participants and, notes the new drug development that will affect new opportunities in this area of medicine.

ANALYST CREDENTIALS

Dr. Marianna Tcherpakov has more than 7 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, and industrial assay development. She holds her PhD in Molecular Neurobiology and has contributed to a number of scientific publications related to research into central nervous system diseases.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
RELATED REPORTS
Share This Report